ACROBiosystems

ACRO Biosystems作为专注于抗体药研发领域的靶点蛋白供应商，利用其专业的蛋白研发平台和生物素标记平台，开发了一系列生物素标记蛋白、适用于特异性检测CAR表达阳性率的CAR-T靶点蛋白、免疫检查点蛋白、Fc 受体蛋白等药物研发用的重组蛋白，广泛用于动物免疫、抗体药筛选、PK实验等药物研发环节。

ACRO Biosystems作为专注于抗体药研发领域的靶点蛋白供应商，利用其专业的蛋白研发平台和生物素标记平台，开发了一系列生物素标记蛋白、适用于特异性检测CAR表达阳性率的CAR-T靶点蛋白、免疫检查点蛋白、Fc 受体蛋白等药物研发用的重组蛋白，广泛用于动物免疫、抗体药筛选、PK实验等药物研发环节。

In our efforts to provide the right blend of innovation and value to our clients, ACROBiosystems scientists have implemented mastered numerous assay platforms over the years. We opened the Innovation Lab in Wilmington Delaware, to further develop technologies and services that complement the existing portfolio of over 1000 recombinant proteins. New technologies are in the pipeline and soon to be released, adding even more benefit to development of Immune Oncology Targets.